{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:18:02Z","timestamp":1789507082654,"version":"build-2803163510"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00284-026-04813-5","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:15:23Z","timestamp":1773994523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An update on Escalating Drug Resistance among Uropathogenic Bacteria: Challenges in Treatment and Scope for Maneuver"],"prefix":"10.1007","volume":"83","author":[{"given":"Mohd","family":"Asim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ahmed","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4239-4808","authenticated-orcid":false,"given":"Qazi Mohd Rizwanul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"4813_CR1","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00345-019-03071-4","volume":"38","author":"R \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk R, Murt A (2020) Epidemiology of urological infections: a global burden. World J Urol 38:2669\u20132679","journal-title":"World J Urol"},{"key":"4813_CR2","doi-asserted-by":"publisher","first-page":"1402941","DOI":"10.3389\/fcimb.2024.1402941","volume":"14","author":"S Sujith","year":"2024","unstructured":"Sujith S, Solomon AP, Rayappan JBB (2024) Comprehensive insights into UTIs: from pathophysiology to precision diagnosis and management. Front Cell Infect Microbiol 14:1402941","journal-title":"Front Cell Infect Microbiol"},{"key":"4813_CR3","doi-asserted-by":"publisher","first-page":"S437","DOI":"10.1093\/cid\/cir110","volume":"52","author":"JF Fisher","year":"2011","unstructured":"Fisher JF, Kavanagh K, Sobel JD et al (2011) Candida urinary tract infection: pathogenesis. Clin Infect Dis 52:S437\u2013S451","journal-title":"Clin Infect Dis"},{"key":"4813_CR4","first-page":"1","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B (2014) Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Disease Clin 28:1\u201313","journal-title":"Infect Disease Clin"},{"key":"4813_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/postgradmedj-2020-139090","volume":"97","author":"R Kaur","year":"2021","unstructured":"Kaur R, Kaur R (2021) Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad Med J 97:803\u2013812. https:\/\/doi.org\/10.1136\/postgradmedj-2020-139090","journal-title":"Postgrad Med J"},{"key":"4813_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molimm.2019.02.007","volume":"108","author":"MR Asadi Karam","year":"2019","unstructured":"Asadi Karam MR, Habibi M, Bouzari S (2019) Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Mol Immunol 108:56\u201367. https:\/\/doi.org\/10.1016\/j.molimm.2019.02.007","journal-title":"Mol Immunol"},{"key":"4813_CR7","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.molmed.2016.09.003","volume":"22","author":"LK McLellan","year":"2016","unstructured":"McLellan LK, Hunstad DA (2016) Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol Med 22:946\u2013957. https:\/\/doi.org\/10.1016\/j.molmed.2016.09.003","journal-title":"Trends Mol Med"},{"key":"4813_CR8","doi-asserted-by":"publisher","unstructured":"Me\u0161trovi\u0107 T, Matija\u0161i\u0107 M, Peri\u0107 M et al (2021) The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside. https:\/\/doi.org\/10.3390\/diagnostics11010007. Diagnostics 11:","DOI":"10.3390\/diagnostics11010007"},{"key":"4813_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fcimb.2017.00241","volume":"7","author":"R Mann","year":"2017","unstructured":"Mann R, Mediati DG, Duggin IG et al (2017) Metabolic adaptations of uropathogenic E. coli in the urinary tract. Front Cell Infect Microbiol 7:241","journal-title":"Front Cell Infect Microbiol"},{"key":"4813_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13756-019-0663-7","volume":"9","author":"E Vandael","year":"2020","unstructured":"Vandael E, Latour K, Goossens H et al (2020) Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017. Antimicrob Resist Infect Control 9:13. https:\/\/doi.org\/10.1186\/s13756-019-0663-7","journal-title":"Antimicrob Resist Infect Control"},{"key":"4813_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1517\/13543784.2016.1161024","volume":"25","author":"MM Zacch\u00e8","year":"2016","unstructured":"Zacch\u00e8 MM, Giarenis I (2016) Therapies in early development for the treatment of urinary tract inflammation. Expert Opin Investig Drugs 25:531\u2013540","journal-title":"Expert Opin Investig Drugs"},{"key":"4813_CR12","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3389\/fmicb.2017.01566","volume":"8","author":"ME Terlizzi","year":"2017","unstructured":"Terlizzi ME, Gribaudo G, Maffei ME (2017) UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol 8:1566","journal-title":"Front Microbiol"},{"key":"4813_CR13","doi-asserted-by":"crossref","unstructured":"Schneeberger C, Kazemier BM, Geerlings SE (2014) Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr Opin Infect Dis 27","DOI":"10.1097\/QCO.0000000000000028"},{"key":"4813_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eursup.2016.04.003","volume":"15","author":"R Bartoletti","year":"2016","unstructured":"Bartoletti R, Cai T, Wagenlehner FM et al (2016) Treatment of Urinary Tract Infections and Antibiotic Stewardship. Eur Urol Supplements 15:81\u201387. https:\/\/doi.org\/10.1016\/j.eursup.2016.04.003","journal-title":"Eur Urol Supplements"},{"key":"4813_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/fmb-2016-0145","volume":"12","author":"A Guglietta","year":"2017","unstructured":"Guglietta A (2017) Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiol 12:239\u2013246","journal-title":"Future Microbiol"},{"key":"4813_CR16","doi-asserted-by":"publisher","first-page":"104196","DOI":"10.1016\/j.micpath.2020.104196","volume":"144","author":"F Zhao","year":"2020","unstructured":"Zhao F, Yang H, Bi D et al (2020) A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections. Microb Pathog 144:104196","journal-title":"Microb Pathog"},{"key":"4813_CR17","doi-asserted-by":"publisher","first-page":"ITC49","DOI":"10.7326\/AITC201710030","volume":"167","author":"K Gupta","year":"2017","unstructured":"Gupta K, Grigoryan L, Trautner B (2017) Urinary tract infection. Ann Intern Med 167:ITC49\u2013ITC64","journal-title":"Ann Intern Med"},{"key":"4813_CR18","first-page":"105","volume":"131","author":"V Skerk","year":"2009","unstructured":"Skerk V, Andrasevi\u0107 A, Andrasevi\u0107 S et al (2009) [ISKRA guidelines on antimicrobial treatment and prophylaxis of urinary tract infections\u2013Croatian national guidelines]. Lijec Vjesn 131:105\u2013118","journal-title":"Lijec Vjesn"},{"key":"4813_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1872213X13666181228154940","volume":"13","author":"AKC Leung","year":"2019","unstructured":"Leung AKC, Wong AHC, Leung AAM, Hon KL (2019) Urinary tract infection in children. Recent Pat Inflamm Allergy Drug Discov 13:2\u201318","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"4813_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10388","volume":"477","author":"VM D\u2019Costa","year":"2011","unstructured":"D\u2019Costa VM, King CE, Kalan L et al (2011) Antibiotic resistance is ancient. Nature 477:457\u2013461","journal-title":"Nature"},{"key":"4813_CR21","unstructured":"(2020) US Centres for Disease Control and Prevention (CDC) About antibiotic resistance"},{"key":"4813_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/bmj.317.7159.647","volume":"317","author":"CA Hart","year":"1998","unstructured":"Hart CA, Kariuki S (1998) Antimicrobial resistance in developing countries. BMJ 317:647. https:\/\/doi.org\/10.1136\/bmj.317.7159.647","journal-title":"BMJ"},{"key":"4813_CR23","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11033-018-4254-0","volume":"45","author":"W Adamus-Bia\u0142ek","year":"2018","unstructured":"Adamus-Bia\u0142ek W, Baraniak A, Wawszczak M et al (2018) The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains. Mol Biol Rep 45:1055\u20131065. https:\/\/doi.org\/10.1007\/s11033-018-4254-0","journal-title":"Mol Biol Rep"},{"key":"4813_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/pathogens5010010","volume":"5","author":"F Wagenlehner","year":"2016","unstructured":"Wagenlehner F, Tandogdu Z, Bartoletti R et al (2016) The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens 5:10","journal-title":"Pathogens"},{"key":"4813_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","volume":"86","author":"J Kranz","year":"2024","unstructured":"Kranz J, Bartoletti R, Bruy\u00e8re F et al (2024) European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. Eur Urol 86:27\u201341. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.035","journal-title":"Eur Urol"},{"key":"4813_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4212\/cjhp.v70i2.1648","volume":"70","author":"A Cheung","year":"2017","unstructured":"Cheung A, Karmali G, Noble S, Song H (2017) Antimicrobial stewardship initiative in treatment of urinary tract infections at a rehabilitation and complex continuing care hospital. Can J Hosp Pharm 70:144","journal-title":"Can J Hosp Pharm"},{"key":"4813_CR27","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.bjid.2022.102366","volume":"26","author":"ZN Tano","year":"2022","unstructured":"Tano ZN, Kobayashi RK, Candido EP et al (2022) Susceptibility to first choice antimicrobial treatment for urinary tract infections to Escherichia coli isolates from women urine samples in community South Brazil. Brazilian J Infect Dis 26:102366","journal-title":"Brazilian J Infect Dis"},{"key":"4813_CR28","doi-asserted-by":"publisher","unstructured":"Poormehr P, Behzadi A, Talebi Ahoi M et al (2025) Phenotypic and Molecular Analysis of Fosfomycin Resistance Among P. aeruginosa Isolates from Cystic Fibrosis Patients. Infect Drug Resist 6203\u20136216. https:\/\/doi.org\/10.2147\/IDR.S552408","DOI":"10.2147\/IDR.S552408"},{"key":"4813_CR29","doi-asserted-by":"crossref","unstructured":"Smriti S, Panda SS, Dash RK et al (2025) Antibiogram of Escherichia coli and Klebsiella pneumoniae Urinary Isolates and Susceptibility of Amikacin in Extended-spectrum Beta-Lactamase Producers. J Pure Appl Microbiol 19","DOI":"10.22207\/JPAM.19.1.62"},{"key":"4813_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/antibiotics9090630","volume":"9","author":"J Hrbacek","year":"2020","unstructured":"Hrbacek J, Cermak P, Zachoval R (2020) Current antibiotic resistance trends of uropathogens in Central Europe: Survey from a Tertiary hospital urology department 2011\u20132019. Antibiotics 9:630","journal-title":"Antibiotics"},{"key":"4813_CR31","doi-asserted-by":"publisher","first-page":"965053","DOI":"10.3389\/fmicb.2022.965053","volume":"13","author":"K Bhargava","year":"2022","unstructured":"Bhargava K, Nath G, Bhargava A et al (2022) Bacterial profile and antibiotic susceptibility pattern of uropathogens causing urinary tract infection in the eastern part of Northern India. Front Microbiol 13:965053","journal-title":"Front Microbiol"},{"key":"4813_CR32","doi-asserted-by":"crossref","unstructured":"Momenah AM, Bakri RA, Jalal NA et al (2023) Antimicrobial resistance pattern of Pseudomonas aeruginosa: An 11-year experience in a tertiary care hospital in Makkah, Saudi Arabia. Infect Drug Resist 4113\u20134122","DOI":"10.2147\/IDR.S409726"},{"key":"4813_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.9734\/ijpr\/2025\/v14i1338","volume":"14","author":"OW Ordu","year":"2025","unstructured":"Ordu OW, Mbata CA, Monsi TP (2025) Molecular Profiling of Antibiotic-resistant Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infections in Rivers State University Teaching Hospital. Int J Pathogen Res 14:27\u201341","journal-title":"Int J Pathogen Res"},{"key":"4813_CR34","doi-asserted-by":"publisher","unstructured":"Bazira J, Pauline Petra N, Nakato CN et al (2025) Trends in Antibiotic Resistance in Uropathogens at Mbarara Regional Referral Hospital (2019\u20132024): A Retrospective Study. Infect Drug Resist 3875\u20133890. https:\/\/doi.org\/10.2147\/IDR.S523848","DOI":"10.2147\/IDR.S523848"},{"key":"4813_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13756-023-01233-z","volume":"12","author":"S Mohapatra","year":"2023","unstructured":"Mohapatra S, Ghosh D, Vivekanandan P et al (2023) Genome profiling of uropathogenic E. coli from strictly defined community-acquired UTI in paediatric patients: a multicentric study. Antimicrob Resist Infect Control 12:36","journal-title":"Antimicrob Resist Infect Control"},{"key":"4813_CR36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12879-023-08641-x","volume":"23","author":"EM Mlugu","year":"2023","unstructured":"Mlugu EM, Mohamedi JA, Sangeda RZ, Mwambete KD (2023) Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in morogoro, Tanzania: a cross-sectional study. BMC Infect Dis 23:660","journal-title":"BMC Infect Dis"},{"key":"4813_CR37","doi-asserted-by":"publisher","first-page":"1517476","DOI":"10.3389\/fepid.2025.1517476","volume":"5","author":"S Fekadu","year":"2025","unstructured":"Fekadu S, Weldegebreal F, Shumie T, Mekonnen GK (2025) A comparative study on nosocomial and community-acquired bacterial urinary tract infections: prevalence, antimicrobial susceptibility pattern, and associated risk factors among symptomatic patients attending Hiwot Fana Comprehensive Specialized University Hospital, Eastern Ethiopia. Front Epidemiol 5:1517476","journal-title":"Front Epidemiol"},{"key":"4813_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12879-024-09086-6","volume":"24","author":"M Shaker","year":"2024","unstructured":"Shaker M, Zaki A, Asser SL, Sayed I El (2024) Trends and predictors of antimicrobial resistance among patients with urinary tract infections at a tertiary hospital facility in Alexandria, Egypt: a retrospective record-based classification and regression tree analysis. BMC Infect Dis 24:246","journal-title":"BMC Infect Dis"},{"key":"4813_CR39","doi-asserted-by":"publisher","first-page":"205031212312208","DOI":"10.1177\/20503121231220821","volume":"11","author":"BK Sah","year":"2023","unstructured":"Sah BK, Dahal P, Mallik SK et al (2023) Uropathogens and their antimicrobial-resistant pattern among suspected urinary tract infections patients in eastern Nepal: A hospital inpatients-based study. SAGE Open Med 11:20503121231220820","journal-title":"SAGE Open Med"},{"key":"4813_CR40","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1093\/jac\/dkaf305","volume":"80","author":"C Larkin","year":"2025","unstructured":"Larkin C, Valappil SP, Palanisamy N (2025) Global prevalence of nitrofurantoin-resistant uropathogenic Escherichia coli (UPEC) in humans: a systematic review and meta-analysis. J Antimicrob Chemother 80:2609\u20132621","journal-title":"J Antimicrob Chemother"},{"key":"4813_CR41","doi-asserted-by":"publisher","first-page":"000321","DOI":"10.1099\/acmi.0.000321","volume":"4","author":"S Mohapatra","year":"2022","unstructured":"Mohapatra S, Panigrahy R, Tak V et al (2022) Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiol 4:000321","journal-title":"Access Microbiol"},{"key":"4813_CR42","first-page":"508","volume":"53","author":"A Fakhri-Demeshghieh","year":"2024","unstructured":"Fakhri-Demeshghieh A, Shokri A, Bokaie S (2024) Antibiotic Resistance of Uropathogenic Escherichia coli (UPEC) among Iranian Pediatrics: Systematic Review and Meta-analysis. Iran J Public Health 53:508\u2013523","journal-title":"Iran J Public Health"},{"key":"4813_CR43","doi-asserted-by":"publisher","first-page":"1553943","DOI":"10.3389\/fmicb.2025.1553943","volume":"16","author":"M Neelambike Sumana","year":"2025","unstructured":"Neelambike Sumana M, Maheshwarappa YD, G K, et al (2025) A retrospective study of the antimicrobial susceptibility patterns of Klebsiella pneumoniae isolated from urine samples over a decade in South India. Front Microbiol 16:1553943","journal-title":"Front Microbiol"},{"key":"4813_CR44","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1017\/ash.2024.419","volume":"4","author":"S Bhat","year":"2024","unstructured":"Bhat S, Gunawardana DU, Boparai DK et al (2024) Antibiogram pattern of Enterococcus species among urinary tract-infected patients visiting tertiary care hospital in Karnataka, India. Antimicrob Stewardship Healthc Epidemiol 4:e206","journal-title":"Antimicrob Stewardship Healthc Epidemiol"},{"key":"4813_CR45","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/antibiotics11060768","volume":"11","author":"A Silva","year":"2022","unstructured":"Silva A, Costa E, Freitas A, Almeida A (2022) Revisiting the frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections. Antibiotics 11:768","journal-title":"Antibiotics"},{"key":"4813_CR46","doi-asserted-by":"publisher","first-page":"2101012","DOI":"10.2807\/1560-7917.ES.2022.27.30.2101012","volume":"27","author":"J Salm","year":"2022","unstructured":"Salm J, Salm F, Arendarski P, Kramer TS (2022) High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020. Eurosurveillance 27:2101012","journal-title":"Eurosurveillance"},{"key":"4813_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","volume":"21","author":"EM Darby","year":"2023","unstructured":"Darby EM, Trampari E, Siasat P et al (2023) Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol 21:280\u2013295","journal-title":"Nat Rev Microbiol"},{"key":"4813_CR48","doi-asserted-by":"publisher","unstructured":"Poirel L, Madec JY, Lupo A et al (2018) Antimicrobial resistance in Escherichia coli. Microbiol Spectr. 2018; 6 (4). https:\/\/doi.org\/10.1128\/microbiolspec ARBA-0026-2017","DOI":"10.1128\/microbiolspec"},{"key":"4813_CR49","doi-asserted-by":"publisher","first-page":"23951","DOI":"10.1038\/s41598-025-08445-w","volume":"15","author":"Y Alraey","year":"2025","unstructured":"Alraey Y, Assiry MM, Ahmad I et al (2025) Antimicrobial resistance and beta-lactamase gene distribution among clinical isolates: a two-year cohort study. Sci Rep 15:23951","journal-title":"Sci Rep"},{"key":"4813_CR50","doi-asserted-by":"publisher","first-page":"9070","DOI":"10.1038\/s41467-024-53192-7","volume":"15","author":"J Lawrence","year":"2024","unstructured":"Lawrence J, O\u2019Hare D, van Batenburg-Sherwood J et al (2024) Innovative approaches in phenotypic beta-lactamase detection for personalised infection management. Nat Commun 15:9070","journal-title":"Nat Commun"},{"key":"4813_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13756-024-01403-7","volume":"13","author":"DM Venne","year":"2024","unstructured":"Venne DM, Hartley DM, Malchione MD et al (2024) Correction: Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa. Antimicrob Resist Infect Control 13:51","journal-title":"Antimicrob Resist Infect Control"},{"key":"4813_CR52","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1093\/jac\/dkae161","volume":"79","author":"M Ivanova","year":"2024","unstructured":"Ivanova M, Ovsepian A, Leekitcharoenphon P et al (2024) Azithromycin resistance in Escherichia coli and Salmonella from food-producing animals and meat in Europe. J Antimicrob Chemother 79:1657\u20131667","journal-title":"J Antimicrob Chemother"},{"key":"4813_CR53","doi-asserted-by":"publisher","first-page":"1387497","DOI":"10.3389\/fcimb.2024.1387497","volume":"14","author":"S Nasrollahian","year":"2024","unstructured":"Nasrollahian S, Graham JP, Halaji M (2024) A review of the mechanisms that confer antibiotic resistance in pathotypes of E. coli. Front Cell Infect Microbiol 14:1387497","journal-title":"Front Cell Infect Microbiol"},{"key":"4813_CR54","doi-asserted-by":"publisher","first-page":"1289396","DOI":"10.3389\/fcimb.2024.1289396","volume":"14","author":"L Korczak","year":"2024","unstructured":"Korczak L, Majewski P, Iwaniuk D et al (2024) Molecular mechanisms of tigecycline-resistance among Enterobacterales. Front Cell Infect Microbiol 14:1289396","journal-title":"Front Cell Infect Microbiol"},{"key":"4813_CR55","first-page":"51","volume":"8","author":"CR Tjampakasari","year":"2024","unstructured":"Tjampakasari CR (2024) Dihydrofolate Reductase (dfr) and Dihydropteroate Synthase (sul) Gene Mutations in Escherichia coli Trimethoprim-Sulfamethoxazole Resistance. Indonesian J Biotechnol Biodivers 8:51\u201359","journal-title":"Indonesian J Biotechnol Biodivers"},{"key":"4813_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jgar.2021.02.020","volume":"25","author":"P Lan","year":"2021","unstructured":"Lan P, Jiang Y, Zhou J, Yu Y (2021) A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist 25:26\u201334","journal-title":"J Glob Antimicrob Resist"},{"key":"4813_CR57","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/antibiotics13100950","volume":"13","author":"S Sabtcheva","year":"2024","unstructured":"Sabtcheva S, Stoikov I, Georgieva S et al (2024) Genomic Characterization of 16S rRNA Methyltransferase-Producing Enterobacterales Reveals the Emergence of Klebsiella pneumoniae ST6260 Harboring rmtF, rmtB, bla NDM-5, bla OXA-232 and bla SFO-1 Genes in a Cancer Hospital in Bulgaria. Antibiotics 13:950","journal-title":"Antibiotics"},{"key":"4813_CR58","doi-asserted-by":"publisher","first-page":"e0289359","DOI":"10.1371\/journal.pone.0289359","volume":"18","author":"OB Ahmed","year":"2023","unstructured":"Ahmed OB, Asghar AH, Bamaga M et al (2023) Characterization of aminoglycoside resistance genes in multidrug-resistant Klebsiella pneumoniae collected from tertiary hospitals during the COVID-19 pandemic. PLoS ONE 18:e0289359","journal-title":"PLoS ONE"},{"key":"4813_CR59","doi-asserted-by":"publisher","first-page":"dlae127","DOI":"10.1093\/jacamr\/dlae127","volume":"6","author":"L Kherroubi","year":"2024","unstructured":"Kherroubi L, Bacon J, Rahman KM (2024) Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation. JAC Antimicrob Resist 6:dlae127","journal-title":"JAC Antimicrob Resist"},{"key":"4813_CR60","doi-asserted-by":"publisher","first-page":"e00016","DOI":"10.1128\/iai.00016-24","volume":"92","author":"G Bhushan","year":"2024","unstructured":"Bhushan G, Castano V, Wong Fok Lung T et al (2024) Lipid A modification of colistin-resistant Klebsiella pneumoniae does not alter innate immune response in a mouse model of pneumonia. Infect Immun 92:e00016\u201324","journal-title":"Infect Immun"},{"key":"4813_CR61","doi-asserted-by":"publisher","first-page":"116408","DOI":"10.1016\/j.diagmicrobio.2024.116408","volume":"110","author":"T M\u00fcderris","year":"2024","unstructured":"M\u00fcderris T, Manyasl\u0131 GD, Kaya S, Yurtsever SG (2024) In vitro interactions of combinations of colistin with meropenem, rifampicin and tigecycline in colistin-resistant, biofilm-forming Klebsiella pneumoniae. Diagn Microbiol Infect Dis 110:116408","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4813_CR62","doi-asserted-by":"crossref","unstructured":"Lu Z, Mclnnes RS, Allen F et al (2025) Resistance to last-resort antibiotics in enterococci. FEMS Microbiol Rev fuaf057","DOI":"10.1093\/femsre\/fuaf057"},{"key":"4813_CR63","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1586\/14787210.2014.956092","volume":"12","author":"WR Miller","year":"2014","unstructured":"Miller WR, Munita JM, Arias CA (2014) Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther 12:1221\u20131236","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4813_CR64","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4161\/viru.21282","volume":"3","author":"BL Hollenbeck","year":"2012","unstructured":"Hollenbeck BL, Rice LB (2012) Intrinsic and acquired resistance mechanisms in Enterococcus. Virulence 3:421\u2013569","journal-title":"Virulence"},{"key":"4813_CR65","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.13005\/bpj\/2221","volume":"14","author":"R Rajan","year":"2021","unstructured":"Rajan R, Karthikeyan D (2021) A Study On High and Low level Drug Resistance Pattern among Clinical Isolates of Enterococci. Biomedical Pharmacol J 14:1189\u20131197","journal-title":"Biomedical Pharmacol J"},{"key":"4813_CR66","unstructured":"Shanmugasundaram M, BackiaSubramanian M, Mariappan S (2025) Enterococcus Species in Clinical Settings: Review on Virulence, Antibiotic Resistance, and Management Strategies"},{"key":"4813_CR67","doi-asserted-by":"publisher","first-page":"1505674","DOI":"10.3389\/fphar.2025.1505674","volume":"16","author":"C Huang","year":"2025","unstructured":"Huang C, Moradi S, Sholeh M et al (2025) Global trends in antimicrobial resistance of Enterococcus faecium: a systematic review and meta-analysis of clinical isolates. Front Pharmacol 16:1505674","journal-title":"Front Pharmacol"},{"key":"4813_CR68","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3390\/antibiotics13121197","volume":"13","author":"P Rajput","year":"2024","unstructured":"Rajput P, Nahar KS, Rahman KM (2024) Evaluation of antibiotic resistance mechanisms in gram-positive bacteria. Antibiotics 13:1197","journal-title":"Antibiotics"},{"key":"4813_CR69","doi-asserted-by":"publisher","unstructured":"Supandy A, Mills EG, Fam KT et al (2025) Allele-specific effects of mutations in the rifampin resistance-determining region (RRDR) of RpoB on physiology and antibiotic resistance in Enterococcus faecium. mSphere e00506-25. https:\/\/doi.org\/10.1101\/2025.07.25.666922","DOI":"10.1101\/2025.07.25.666922"},{"key":"4813_CR70","doi-asserted-by":"publisher","first-page":"100075","DOI":"10.1016\/j.tcsw.2022.100075","volume":"8","author":"DK Govindarajan","year":"2022","unstructured":"Govindarajan DK, Kandaswamy K (2022) Virulence factors of uropathogens and their role in host pathogen interactions. Cell Surf 8:100075","journal-title":"Cell Surf"},{"key":"4813_CR71","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269\u2013284","journal-title":"Nat Rev Microbiol"},{"key":"4813_CR72","doi-asserted-by":"publisher","unstructured":"Shrestha LB, Baral R, Khanal B (2019) Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections. Infect Drug Resist 957\u2013963. https:\/\/doi.org\/10.2147\/IDR.S200988","DOI":"10.2147\/IDR.S200988"},{"key":"4813_CR73","doi-asserted-by":"publisher","unstructured":"Amankwah S, Abdella K, Kassa T (2021) Bacterial biofilm destruction: A focused review on the recent use of phage-based strategies with other antibiofilm agents. Nanotechnol Sci Appl 161\u2013177. https:\/\/doi.org\/10.2147\/NSA.S325594","DOI":"10.2147\/NSA.S325594"},{"key":"4813_CR74","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jamda.2018.05.001","volume":"19","author":"LW van Buul","year":"2018","unstructured":"van Buul LW, Vreeken HL, Bradley SF et al (2018) The development of a decision tool for the empiric treatment of suspected urinary tract infection in frail older adults: a Delphi consensus procedure. J Am Med Dir Assoc 19:757\u2013764","journal-title":"J Am Med Dir Assoc"},{"key":"4813_CR75","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/332265a0","volume":"332","author":"MS Hanson","year":"1988","unstructured":"Hanson MS, Brinton CC Jr (1988) Identification and characterization of E. coli type-1 pilus tip adhesion protein. Nature 332:265\u2013268","journal-title":"Nature"},{"key":"4813_CR76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1438-4221(00)80102-2","volume":"290","author":"P Klemm","year":"2000","unstructured":"Klemm P, Schembri MA (2000) Bacterial adhesins: function and structure. Int J Med Microbiol 290:27\u201335","journal-title":"Int J Med Microbiol"},{"key":"4813_CR77","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cell.2006.02.012","volume":"124","author":"J Pizarro-Cerd\u00e1","year":"2006","unstructured":"Pizarro-Cerd\u00e1 J, Cossart P (2006) Bacterial adhesion and entry into host cells. Cell 124:715\u2013727","journal-title":"Cell"},{"key":"4813_CR78","doi-asserted-by":"publisher","first-page":"e1007671","DOI":"10.1371\/journal.ppat.1007671","volume":"15","author":"I Ambite","year":"2019","unstructured":"Ambite I, Butler DSC, Stork C et al (2019) Fimbriae reprogram host gene expression\u2013Divergent effects of P and type 1 fimbriae. PLoS Pathog 15:e1007671","journal-title":"PLoS Pathog"},{"key":"4813_CR79","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1128\/jb.170.9.3983-3990.1988","volume":"170","author":"M Ott","year":"1988","unstructured":"Ott M, Hosch\u00fctzky H, Jann K et al (1988) Gene clusters for S fimbrial adhesin (sfa) and F1C fimbriae (foc) of Escherichia coli: comparative aspects of structure and function. J Bacteriol 170:3983\u20133990","journal-title":"J Bacteriol"},{"key":"4813_CR80","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1128\/IAI.73.9.6119-6126.2005","volume":"73","author":"M Das","year":"2005","unstructured":"Das M, Hart-Van Tassell A, Urvil PT et al (2005) Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion. Infect Immun 73:6119\u20136126","journal-title":"Infect Immun"},{"key":"4813_CR81","doi-asserted-by":"publisher","first-page":"12610","DOI":"10.3390\/ijms222212610","volume":"22","author":"F Carlini","year":"2021","unstructured":"Carlini F, Maroccia Z, Fiorentini C et al (2021) Effects of the Escherichia coli bacterial toxin cytotoxic necrotizing factor 1 on different human and animal cells: a systematic review. Int J Mol Sci 22:12610","journal-title":"Int J Mol Sci"},{"key":"4813_CR82","doi-asserted-by":"publisher","first-page":"e1003884","DOI":"10.1371\/journal.ppat.1003884","volume":"10","author":"M Piteau","year":"2014","unstructured":"Piteau M, Papatheodorou P, Schwan C et al (2014) Lu\/BCAM adhesion glycoprotein is a receptor for Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1). PLoS Pathog 10:e1003884","journal-title":"PLoS Pathog"},{"key":"4813_CR83","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbamem.2015.08.015","volume":"1858","author":"LC Ristow","year":"2016","unstructured":"Ristow LC, Welch RA (2016) Hemolysin of uropathogenic Escherichia coli: A cloak or a dagger? Biochim et Biophys Acta (BBA)-Biomembranes 1858:538\u2013545","journal-title":"Biochim et Biophys Acta (BBA)-Biomembranes"},{"key":"4813_CR84","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00838-13","volume":"4","author":"R Nava-Acosta","year":"2013","unstructured":"Nava-Acosta R, Navarro-Garcia F (2013) Cytokeratin 8 is an epithelial cell receptor for Pet, a cytotoxic serine protease autotransporter of Enterobacteriaceae. mBio 4:10\u20131128","journal-title":"mBio"},{"key":"4813_CR85","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1128\/JB.00791-15","volume":"198","author":"KB Nichols","year":"2016","unstructured":"Nichols KB, Totsika M, Moriel DG et al (2016) Molecular characterization of the vacuolating autotransporter toxin in uropathogenic Escherichia coli. J Bacteriol 198:1487\u20131498","journal-title":"J Bacteriol"},{"key":"4813_CR86","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MMBR.00078-15","volume":"80","author":"MK Paczosa","year":"2016","unstructured":"Paczosa MK, Mecsas J (2016) Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev 80:629\u2013661","journal-title":"Microbiol Mol Biol Rev"},{"key":"4813_CR87","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4161\/viru.22974","volume":"4","author":"MD Alc\u00e1ntar-Curiel","year":"2013","unstructured":"Alc\u00e1ntar-Curiel MD, Blackburn D, Salda\u00f1a Z et al (2013) Multi-functional analysis of Klebsiella pneumoniae fimbrial types in adherence and biofilm formation. Virulence 4:129\u2013138","journal-title":"Virulence"},{"key":"4813_CR88","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1128\/iai.60.3.1187-1192.1992","volume":"60","author":"AM Tarkkanen","year":"1992","unstructured":"Tarkkanen AM, Allen BL, Williams PH et al (1992) Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun 60:1187\u20131192","journal-title":"Infect Immun"},{"key":"4813_CR89","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/JB.186.1.154-163.2004","volume":"186","author":"CJ Kristich","year":"2004","unstructured":"Kristich CJ, Li Y-H, Cvitkovitch DG, Dunny GM (2004) Esp-independent biofilm formation by Enterococcus faecalis. J Bacteriol 186:154\u2013163","journal-title":"J Bacteriol"},{"key":"4813_CR90","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1128\/IAI.69.7.4366-4372.2001","volume":"69","author":"N Shankar","year":"2001","unstructured":"Shankar N, Lockatell CV, Baghdayan AS et al (2001) Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun 69:4366\u20134372","journal-title":"Infect Immun"},{"key":"4813_CR91","unstructured":"Ayanto RT (2021) Plasmid PCF10-Mediated Enterococcus faecalis Heterogenous Tower-like Biofilm Structures Influence Biological Properties of the Biofilms. Temple University"},{"key":"4813_CR92","doi-asserted-by":"publisher","first-page":"103344","DOI":"10.1016\/j.fm.2019.103344","volume":"86","author":"F Liu","year":"2020","unstructured":"Liu F, Sun Z, Wang F et al (2020) Inhibition of biofilm formation and exopolysaccharide synthesis of Enterococcus faecalis by phenyllactic acid. Food Microbiol 86:103344","journal-title":"Food Microbiol"},{"key":"4813_CR93","doi-asserted-by":"publisher","unstructured":"Hashem YA, Abdelrahman KA, Aziz RK (2021) Phenotype\u2013genotype correlations and distribution of key virulence factors in Enterococcus faecalis isolated from patients with urinary tract infections. Infect Drug Resist 1713\u20131723 https:\/\/doi.org\/10.2147\/IDR.S305167","DOI":"10.2147\/IDR.S305167"},{"key":"4813_CR94","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00058-18","volume":"32","author":"M Garc\u00eda-Solache","year":"2019","unstructured":"Garc\u00eda-Solache M, Rice LB (2019) The Enterococcus: a model of adaptability to its environment. Clin Microbiol Rev 32:10\u20131128","journal-title":"Clin Microbiol Rev"},{"key":"4813_CR95","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1462-5822.2003.00310.x","volume":"5","author":"PS Coburn","year":"2003","unstructured":"Coburn PS, Gilmore MS (2003) The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell Microbiol 5:661\u2013669","journal-title":"Cell Microbiol"},{"key":"4813_CR96","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1128\/IAI.68.9.5218-5224.2000","volume":"68","author":"SR Nallapareddy","year":"2000","unstructured":"Nallapareddy SR, Qin X, Weinstock GM et al (2000) Enterococcus faecalis adhesin, ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I. Infect Immun 68:5218\u20135224","journal-title":"Infect Immun"},{"key":"4813_CR97","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1086\/367711","volume":"187","author":"LB Rice","year":"2003","unstructured":"Rice LB, Carias L, Rudin S et al (2003) A potential virulence gene, hyl Efm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 187:508\u2013512","journal-title":"J Infect Dis"},{"key":"4813_CR98","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/IAI.00378-17","volume":"85","author":"BYQ Tien","year":"2017","unstructured":"Tien BYQ, Goh HMS, Chong KKL et al (2017) Enterococcus faecalis promotes innate immune suppression and polymicrobial catheter-associated urinary tract infection. Infect Immun 85:10\u20131128","journal-title":"Infect Immun"},{"key":"4813_CR99","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1086\/341977","volume":"35","author":"EN Vergis","year":"2002","unstructured":"Vergis EN, Shankar N, Chow JW et al (2002) Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. Clin Infect Dis 35:570\u2013575","journal-title":"Clin Infect Dis"},{"key":"4813_CR100","doi-asserted-by":"publisher","first-page":"e112010","DOI":"10.1371\/journal.pone.0112010","volume":"9","author":"J Zou","year":"2014","unstructured":"Zou J, Baghdayan AS, Payne SJ, Shankar N (2014) A TIR domain protein from E. faecalis attenuates MyD88-mediated signaling and NF-\u03baB activation. PLoS ONE 9:e112010","journal-title":"PLoS ONE"},{"key":"4813_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06435-7","volume":"21","author":"GK Bunduki","year":"2021","unstructured":"Bunduki GK, Heinz E, Phiri VS et al (2021) Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis. BMC Infect Dis 21:1\u201313","journal-title":"BMC Infect Dis"},{"key":"4813_CR102","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/microorganisms10071425","volume":"10","author":"C Zagaglia","year":"2022","unstructured":"Zagaglia C, Ammendolia MG, Maurizi L et al (2022) Urinary tract infections caused by uropathogenic Escherichia coli strains\u2014new strategies for an old pathogen. Microorganisms 10:1425","journal-title":"Microorganisms"},{"key":"4813_CR103","doi-asserted-by":"publisher","first-page":"e66481","DOI":"10.7554\/eLife.66481","volume":"10","author":"K Sharma","year":"2021","unstructured":"Sharma K, Dhar N, Thacker VV et al (2021) Dynamic persistence of UPEC intracellular bacterial communities in a human bladder-chip model of urinary tract infection. Elife 10:e66481","journal-title":"Elife"},{"key":"4813_CR104","doi-asserted-by":"publisher","first-page":"15530","DOI":"10.1073\/pnas.1315203110","volume":"110","author":"DJ Schwartz","year":"2013","unstructured":"Schwartz DJ, Kalas V, Pinkner JS et al (2013) Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci 110:15530\u201315537","journal-title":"Proc Natl Acad Sci"},{"key":"4813_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-019-1587-3","volume":"19","author":"C Shah","year":"2019","unstructured":"Shah C, Baral R, Bartaula B, Shrestha LB (2019) Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol 19:1\u20136","journal-title":"BMC Microbiol"},{"key":"4813_CR106","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.ki.5002230","volume":"72","author":"MC Lane","year":"2007","unstructured":"Lane MC, Mobley HLT (2007) Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int 72:19\u201325","journal-title":"Kidney Int"},{"key":"4813_CR107","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/pathogens10111355","volume":"10","author":"VM Sora","year":"2021","unstructured":"Sora VM, Meroni G, Martino PA et al (2021) Extraintestinal pathogenic Escherichia coli: virulence factors and antibiotic resistance. Pathogens 10:1355","journal-title":"Pathogens"},{"key":"4813_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-019-0343-8","volume":"19","author":"CY Effah","year":"2020","unstructured":"Effah CY, Sun T, Liu S, Wu Y (2020) Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob 19:1\u20139","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"4813_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-10-179","volume":"10","author":"C Schroll","year":"2010","unstructured":"Schroll C, Barken KB, Krogfelt KA, Struve C (2010) Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol 10:1\u201310","journal-title":"BMC Microbiol"},{"key":"4813_CR110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/pathogens12010034","volume":"12","author":"MA Khalil","year":"2022","unstructured":"Khalil MA, Alorabi JA, Al-Otaibi LM et al (2022) Antibiotic resistance and biofilm formation in Enterococcus spp. isolated from urinary tract infections. Pathogens 12:34","journal-title":"Pathogens"},{"key":"4813_CR111","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1086\/517524","volume":"195","author":"KV Singh","year":"2007","unstructured":"Singh KV, Nallapareddy SR, Murray BE (2007) Importance of the ebp (endocarditisand biofilm-associated pilus) locus in the pathogenesis of Enterococcus faecalis ascending urinary tract infection. J Infect Dis 195:1671\u20131677","journal-title":"J Infect Dis"},{"key":"4813_CR112","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.juro.2016.01.100","volume":"196","author":"AL Flores-Mireles","year":"2016","unstructured":"Flores-Mireles AL, Walker JN, Bauman TM et al (2016) Fibrinogen release and deposition on urinary catheters placed during urological procedures. J Urol 196:416\u2013421","journal-title":"J Urol"},{"key":"4813_CR113","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41579-020-0324-0","volume":"18","author":"RD Klein","year":"2020","unstructured":"Klein RD, Hultgren SJ (2020) Urinary tract infections: microbial pathogenesis, host\u2013pathogen interactions and new treatment strategies. Nat Rev Microbiol 18:211\u2013226","journal-title":"Nat Rev Microbiol"},{"key":"4813_CR114","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.3390\/diagnostics15192469","volume":"15","author":"B Baimakhanova","year":"2025","unstructured":"Baimakhanova B, Sadanov A, Berezin V et al (2025) Emerging Technologies for the Diagnosis of Urinary Tract Infections: Advances in Molecular Detection and Resistance Profiling. Diagnostics 15:2469","journal-title":"Diagnostics"},{"key":"4813_CR115","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14777\/uti.2550020010","volume":"20","author":"JVA Franco","year":"2025","unstructured":"Franco JVA, Meza N (2025) Advances in the diagnosis of urinary tract infection: a narrative review. Urogenit Tract Infect 20:17\u201327","journal-title":"Urogenit Tract Infect"},{"key":"4813_CR116","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/biomedicines13051066","volume":"13","author":"A-E Topa","year":"2025","unstructured":"Topa A-E, Ionescu C, Pinzaru A et al (2025) Challenges in the Treatment of Urinary Tract Infections: Antibiotic Resistance Profiles of Escherichia coli Strains Isolated from Young and Elderly Patients in a Southeastern Romanian Hospital. Biomedicines 13:1066","journal-title":"Biomedicines"},{"key":"4813_CR117","doi-asserted-by":"publisher","first-page":"7","DOI":"10.24018\/clinicmed.2025.6.1.370","volume":"6","author":"A Srivastava","year":"2025","unstructured":"Srivastava A, Kadam SJ, Sharma R (2025) ESBL\u2014Multi-Drug-Resistant UTI Creating Outpatient Treatment Challenge. Eur J Clin Med 6:7\u201310","journal-title":"Eur J Clin Med"},{"key":"4813_CR118","first-page":"1982","volume":"331","author":"E Harris","year":"2024","unstructured":"Harris E (2024) New Drug for UTIs Gets the Greenlight. JAMA 331:1982\u20131983","journal-title":"JAMA"},{"key":"4813_CR119","doi-asserted-by":"publisher","first-page":"592","DOI":"10.4161\/viru.22364","volume":"3","author":"M Kostakioti","year":"2012","unstructured":"Kostakioti M, Hultgren SJ, Hadjifrangiskou M (2012) Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics. Virulence 3:592\u2013593","journal-title":"Virulence"},{"key":"4813_CR120","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrurol.2010.190","volume":"7","author":"B Foxman","year":"2010","unstructured":"Foxman B (2010) The epidemiology of urinary tract infection. Nat Rev Urol 7:653\u2013660","journal-title":"Nat Rev Urol"},{"key":"4813_CR121","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40265-013-0013-7","volume":"73","author":"GG Zhanel","year":"2013","unstructured":"Zhanel GG, Lawson CD, Adam H et al (2013) Ceftazidime-avibactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination. Drugs 73:159\u2013177","journal-title":"Drugs"},{"key":"4813_CR122","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/jac\/dkt118","volume":"68","author":"DM Livermore","year":"2013","unstructured":"Livermore DM, Mushtaq S (2013) Activity of biapenem (RPX2003) combined with the boronate \u03b2-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae. J Antimicrob Chemother 68:1825\u20131831","journal-title":"J Antimicrob Chemother"},{"key":"4813_CR123","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/jac\/dkt050","volume":"68","author":"S Mushtaq","year":"2013","unstructured":"Mushtaq S, Woodford N, Hope R et al (2013) Activity of BAL30072 alone or combined with \u03b2-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters. J Antimicrob Chemother 68:1601\u20131608","journal-title":"J Antimicrob Chemother"},{"key":"4813_CR124","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1080\/21645515.2020.1834807","volume":"17","author":"GR Eldridge","year":"2021","unstructured":"Eldridge GR, Hughey H, Rosenberger L et al (2021) Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study. Hum Vaccin Immunother 17:1262\u20131270","journal-title":"Hum Vaccin Immunother"},{"key":"4813_CR125","doi-asserted-by":"publisher","first-page":"1668937","DOI":"10.3389\/fimmu.2025.1668937","volume":"16","author":"S Roier","year":"2025","unstructured":"Roier S, Adamo R, Rosini R et al (2025) An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli is highly immunogenic in rodents. Front Immunol 16:1668937","journal-title":"Front Immunol"},{"key":"4813_CR126","doi-asserted-by":"publisher","unstructured":"Silmon de Monerri NC, Che Y, Lees JA et al (2024) Structure-based design of a highly immunogenic, conformationally stabilized FimH antigen for a urinary tract infection vaccine. bioRxiv 2024\u20132026. https:\/\/doi.org\/10.1371\/journal.ppat.1012325","DOI":"10.1371\/journal.ppat.1012325"},{"key":"4813_CR127","doi-asserted-by":"publisher","first-page":"e1011388","DOI":"10.1371\/journal.ppat.1011388","volume":"19","author":"M Naskar","year":"2023","unstructured":"Naskar M, Parekh VP, Abraham MA et al (2023) \u03b1-Hemolysin promotes uropathogenic E. coli persistence in bladder epithelial cells via abrogating bacteria-harboring lysosome acidification. PLoS Pathog 19:e1011388","journal-title":"PLoS Pathog"},{"key":"4813_CR128","doi-asserted-by":"publisher","first-page":"e00440","DOI":"10.1128\/iai.00440-23","volume":"92","author":"Y Xing","year":"2024","unstructured":"Xing Y, Clark JR, Chang JD et al (2024) Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach. Infect Immun 92:e00440\u2013e00423","journal-title":"Infect Immun"},{"key":"4813_CR129","doi-asserted-by":"publisher","first-page":"e02184","DOI":"10.1128\/mbio.02184-22","volume":"13","author":"RR Gerner","year":"2022","unstructured":"Gerner RR, Hossain S, Sargun A et al (2022) Siderophore immunization restricted colonization of adherent-invasive Escherichia coli and ameliorated experimental colitis. mBio 13:e02184\u2013e02122","journal-title":"mBio"},{"key":"4813_CR130","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/jof8010021","volume":"8","author":"L Pecoraro","year":"2021","unstructured":"Pecoraro L, Wang X, Shah D et al (2021) Biosynthesis pathways, transport mechanisms and biotechnological applications of fungal siderophores. J Fungi 8:21","journal-title":"J Fungi"},{"key":"4813_CR131","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.vaccine.2022.12.057","volume":"41","author":"H Wang","year":"2023","unstructured":"Wang H, Cao L, Logue CM et al (2023) Evaluation of immunogenicity and efficacy of the enterobactin conjugate vaccine in protecting chickens from colibacillosis. Vaccine 41:930\u2013937","journal-title":"Vaccine"},{"key":"4813_CR132","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/vaccines8040747","volume":"8","author":"Y Cui","year":"2020","unstructured":"Cui Y, Guo F, Guo J et al (2020) Immunization of chickens with the enterobactin conjugate vaccine reduced Campylobacter jejuni colonization in the intestine. Vaccines (Basel) 8:747","journal-title":"Vaccines (Basel)"},{"key":"4813_CR133","doi-asserted-by":"publisher","first-page":"589115","DOI":"10.3389\/fcimb.2020.589115","volume":"10","author":"J Wang","year":"2021","unstructured":"Wang J, Xiong K, Pan Q et al (2021) Application of TonB-dependent transporters in vaccine development of gram-negative bacteria. Front Cell Infect Microbiol 10:589115","journal-title":"Front Cell Infect Microbiol"},{"key":"4813_CR134","doi-asserted-by":"publisher","first-page":"1371377","DOI":"10.3389\/fchem.2024.1371377","volume":"12","author":"M Akash","year":"2024","unstructured":"Akash M, Zaib S, Ahmad M et al (2024) Synthesis and biological evaluation of pyridylpiperazine hybrid derivatives as urease inhibitors. Front Chem 12:1371377","journal-title":"Front Chem"},{"key":"4813_CR135","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1039\/D4MD00378K","volume":"15","author":"RA Heylen","year":"2024","unstructured":"Heylen RA, Cusick N, White T et al (2024) Rational design and in vitro testing of new urease inhibitors to prevent urinary catheter blockage. RSC Med Chem 15:3597\u20133608","journal-title":"RSC Med Chem"},{"key":"4813_CR136","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1038\/s41598-021-83257-2","volume":"11","author":"S Milo","year":"2021","unstructured":"Milo S, Heylen RA, Glancy J et al (2021) A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections. Sci Rep 11:3726","journal-title":"Sci Rep"},{"key":"4813_CR137","doi-asserted-by":"publisher","first-page":"17897","DOI":"10.1073\/pnas.0606795103","volume":"103","author":"JS Pinkner","year":"2006","unstructured":"Pinkner JS, Remaut H, Buelens F et al (2006) Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc Natl Acad Sci 103:17897\u201317902","journal-title":"Proc Natl Acad Sci"},{"key":"4813_CR138","doi-asserted-by":"publisher","first-page":"eadp7066","DOI":"10.1126\/sciadv.adp7066","volume":"11","author":"PN Azimzadeh","year":"2025","unstructured":"Azimzadeh PN, Birchenough GM, Gualbuerto NC et al (2025) Mechanisms of uropathogenic E. coli mucosal association in the gastrointestinal tract. Sci Adv 11:eadp7066","journal-title":"Sci Adv"},{"key":"4813_CR139","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12937-022-00769-x","volume":"21","author":"R Ala-Jaakkola","year":"2022","unstructured":"Ala-Jaakkola R, Laitila A, Ouwehand AC, Lehtoranta L (2022) Role of D-mannose in urinary tract infections\u2013a narrative review. Nutr J 21:18","journal-title":"Nutr J"},{"key":"4813_CR140","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/s41467-018-03968-5","volume":"9","author":"K Thomas-White","year":"2018","unstructured":"Thomas-White K, Forster SC, Kumar N et al (2018) Culturing of female bladder bacteria reveals an interconnected urogenital microbiota. Nat Commun 9:1557","journal-title":"Nat Commun"},{"key":"4813_CR141","doi-asserted-by":"publisher","first-page":"617002","DOI":"10.3389\/fcimb.2021.617002","volume":"11","author":"V Perez-Carrasco","year":"2021","unstructured":"Perez-Carrasco V, Soriano-Lerma A, Soriano M et al (2021) Urinary microbiome: yin and yang of the urinary tract. Front Cell Infect Microbiol 11:617002","journal-title":"Front Cell Infect Microbiol"},{"key":"4813_CR142","doi-asserted-by":"publisher","first-page":"20230702","DOI":"10.1515\/med-2023-0702","volume":"18","author":"X Weng","year":"2023","unstructured":"Weng X, Liu Y, Hu H et al (2023) Changes of microbiota level in urinary tract infections: A meta-analysis. Open Med 18:20230702","journal-title":"Open Med"},{"key":"4813_CR143","doi-asserted-by":"publisher","first-page":"127010","DOI":"10.1016\/j.micres.2022.127010","volume":"259","author":"C Kenneally","year":"2022","unstructured":"Kenneally C, Murphy CP, Sleator RD, Culligan EP (2022) The urinary microbiome and biological therapeutics: Novel therapies for urinary tract infections. Microbiol Res 259:127010","journal-title":"Microbiol Res"},{"key":"4813_CR144","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fcimb.2020.00421","volume":"10","author":"S Vasudevan","year":"2020","unstructured":"Vasudevan S, Thamil Selvan G, Bhaskaran S et al (2020) Reciprocal cooperation of type A procyanidin and nitrofurantoin against multi-drug resistant (MDR) UPEC: a pH-dependent study. Front Cell Infect Microbiol 10:421","journal-title":"Front Cell Infect Microbiol"},{"key":"4813_CR145","doi-asserted-by":"publisher","first-page":"112889","DOI":"10.1016\/j.jep.2020.112889","volume":"257","author":"B Scharf","year":"2020","unstructured":"Scharf B, Schmidt TJ, Rabbani S et al (2020) Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry. extract? J Ethnopharmacol 257:112889","journal-title":"extract? J Ethnopharmacol"},{"key":"4813_CR146","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jhin.2006.04.021","volume":"70","author":"S Jahagirdar","year":"2008","unstructured":"Jahagirdar S, Patwardhan R, Dhakephalkar PK (2008) Curing plasmid-mediated vancomycin resistance in Staphylococcus aureus using herbal naphthoquinones. J Hosp Infect 70:289\u2013291","journal-title":"J Hosp Infect"},{"key":"4813_CR147","first-page":"671","volume":"37","author":"V Radhakrishnan","year":"1999","unstructured":"Radhakrishnan V, Ganguly K, Ganguly M et al (1999) Potentiality of tricyclic compound thioridazine as an effective antibacterial and antiplasmid agent. Indian J Exp Biol 37:671\u2013675","journal-title":"Indian J Exp Biol"},{"key":"4813_CR148","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1038\/s41467-024-48219-y","volume":"15","author":"PD Zongo","year":"2024","unstructured":"Zongo PD, Cabanel N, Royer G et al (2024) An antiplasmid system drives antibiotic resistance gene integration in carbapenemase-producing Escherichia coli lineages. Nat Commun 15:4093","journal-title":"Nat Commun"},{"key":"4813_CR149","doi-asserted-by":"publisher","first-page":"102313","DOI":"10.1016\/j.mib.2023.102313","volume":"74","author":"PB Ugarte","year":"2023","unstructured":"Ugarte PB, Barendse P, Swarts DC (2023) Argonaute proteins confer immunity in all domains of life. Curr Opin Microbiol 74:102313","journal-title":"Curr Opin Microbiol"},{"key":"4813_CR150","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1016\/j.cell.2024.07.028","volume":"187","author":"X-Y Yang","year":"2024","unstructured":"Yang X-Y, Shen Z, Wang C et al (2024) DdmDE eliminates plasmid invasion by DNA-guided DNA targeting. Cell 187:5253\u20135266","journal-title":"Cell"},{"key":"4813_CR151","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1016\/j.molcel.2022.09.008","volume":"82","author":"A Deep","year":"2022","unstructured":"Deep A, Gu Y, Gao Y-Q et al (2022) The SMC-family Wadjet complex protects bacteria from plasmid transformation by recognition and cleavage of closed-circular DNA. Mol Cell 82:4145\u20134159","journal-title":"Mol Cell"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04813-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-04813-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04813-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:04Z","timestamp":1777370644000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-04813-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":151,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4813"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-04813-5","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report there are no competing or financial interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"243"}}